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Abstract 
The global epidemic of obesity and type II diabetes has led to a growing interest 
in the underlying mechanisms of metabolic diseases. The peroxisome 
proliferator-activated receptor γ (PPARγ) is a member of the nuclear receptor 
superfamily, and is vital for the transcriptional regulation of adipogenesis, insulin 
sensitivity and lipid metabolism. In the mouse model, it has been demonstrated 
that global knockout of PPARγ leads to severe metabolic disturbance, resulting in 
embryonic lethality. However, the specific regulatory roles of its two protein 
isoforms, PPARγ1 and PPARγ2, remain uncertain, due to limitations of reagents 
and appropriate mouse models. To investigate the hypothesis that PPARγ1 and 
PPARγ2 are functionally distinct, we generated PPARγ1 and PPARγ2 tagged 
mice using CRISPR-Cas9 technology. PPARγ1 and PPARγ2 specific knockout 
mice were also generated incidentally during this process, via aberrant 
recombination. By reverse-transcription quantitative PCR (RT-qPCR), and 
western blot, we confirmed the presence of the appropriate tags in our PPARγ1 
and PPARγ2 tagged mice, with no significant disruption to mRNA or protein 
expression. Furthermore, we found that PPARγ1 mRNA and protein expression 
levels were reduced in our PPARγ1 knockout model, compared to the wild type. 
Interestingly, we found a complete loss of PPARγ2 protein expression, despite an 
increase in PPARγ2 mRNA expression in our PPARγ2 knockout model. These 
data suggest that we have successfully generated PPARγ1 and PPARγ2 knockin 
and knockout mice. Our mouse models provide a valuable tool to study the 
individual roles of PPARγ1 and PPARγ2 in adipogenesis, insulin sensitivity and 
metabolic disease.  
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Figure 3. PCR amplification and DNA sequencing of PPARγ1 mice 
confirming tag insertion and knockout. (A and B) DNA gel electrophoresis of 3HA-
PPARγ1 tagged mice (A) and PPARγ1 knockout mice (B). (C and D) DNA sequencing of 3HA-
PPARγ1 tagged model showing partial genomic sequence with HA tag insertion (C) and 
PPARγ1 knockout model showing partial genomic sequence with creation of a premature stop 
codon (D). The sequence highlighted in red indicates 3HA tag insertion.  
Summary 
• PPARγ1 and PPARγ2 knockin mice were appropriately tagged with 3HA and 6His-HA, 
respectively.  
• PPARγ1 knockout mice demonstrated a reduction in PPARγ1 mRNA and protein  
expression. 
• PPARγ2 knockout mice had a complete loss of PPARγ2 protein expression, despite an 
increase in PPARγ2 mRNA expression.  
Figure 4. mRNA expression in adipose tissue of PPARγ1 and PPARγ2 
knockin and knockout mice. (A-D) Relative mRNA expression in adipose tissue 
biopsies of HA tagged PPARγ1 (A),  PPARγ1 knockout (B),  6His-HA tagged PPARγ2 (C), and 




Figure 5. Protein expression in adipose tissue of PPARγ1 and PPARγ2 
knockin and knockout mice. (A-D) PPARγ1 and PPARγ2 protein expression in 3HA-
PPARγ1 (A), PPARγ1 KO (B), 6His-HA PPARγ2 (C), and PPARγ2 KO (D). Anti-vinculin as 
loading control.  
Conclusion 
• We have generated PPARγ1 and PPARγ2 knockin and knockout mouse models with 
appropriate protein expression.   
• These models will be useful for the future study of the isoform-specific roles of PPARγ1 
and PPARγ2 in metabolic diseases.  
Generating PPARγ1 and PPARγ2 mouse models  
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Figure 1. PPARγ gene gives rise to PPARγ1 and PPARγ2. Diagram depicting the 
transcription of PPARγ1 and PPARγ2 from PPARγ, generated by alternative promoters. PPARγ2 
has an additional 30 N-terminal amino acids, relative to PPARγ1.  
Figure 2. PPARγ1 and PPARγ2 knockin and knockout mice generated by 
CRISPR. (A) 3HA (HA) tag inserted with gRNA targeting exon A2 of PPARγ1. (B) 6 Histidine 
(6His)-Hemagluttinin (HA) tag inserted with gRNA targeting N-terminus of PPARγ2.  
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PPARγ1- 476 amino acids – Expressed in adipose 
tissue, macrophages, skeletal muscle,  liver, and many 
other tissues  
















































































-/- +/- +/+ +/- +/- -/- +/- +/+ +/+ +/+ +/+ +/+ +/- -/- 
AGACTACCCTTTg c c a c c a t g t a t c c a t a c g a t t  
AGACTACCCTTTGCCACCATGTATCCATACGATT 
g t t c c t g a c t a t g c g g g c t a t c c c t a t g a c g t c c    
GTTCCTGACTATGCGGGCTATCCCTATGACGTCC 
cagattacgctACTGGTATGTACATCAGAATAAATTAA   
cagattacgctACTGGTATGTACATCAGAATAAATTAA   
c c g g a c t a t g c a g g a t c g t a t c c t t a t g a c g t t c c    
CCGGACTATGCAGGATCGTATCCTTATGACGTTCC  
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